Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease
Gorm Thorlacius-Ussing, Boye Schnack Nielsen, Vibeke Andersen, et al.
Inflammatory Bowel Diseases (2017) Vol. 23, Iss. 5, pp. 739-752
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation
XU De-sheng, Yan Wang, Zirui Li, et al.
Pharmacological Research (2025), pp. 107725-107725
Open Access
Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer
Trine Møller, Jaslin James, Kim Holmstrøm, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1907-1907
Open Access | Times Cited: 31
Aberrant expression of miR-21 in patients with inflammatory bowel disease
Huimin Yan, Xinyu Zhang, Yi Xu
Medicine (2020) Vol. 99, Iss. 17, pp. e19693-e19693
Open Access | Times Cited: 30
The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target
Golamreza Jadideslam, Khalil Ansarin, Ebrahim Sakhinia, et al.
Journal of Cellular Physiology (2018) Vol. 233, Iss. 12, pp. 9209-9222
Closed Access | Times Cited: 30
Deep Dive Into MicroRNAs in Inflammatory Bowel Disease
Jaber Alfaifi, Adeline Germain, Anne-Charlotte Heba, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 6, pp. 986-999
Open Access | Times Cited: 15
MiR‐126 correlates with increased disease severity and promotes keratinocytes proliferation and inflammation while suppresses cells' apoptosis in psoriasis
Shike Feng, Lin Wang, Wang Liu, et al.
Journal of Clinical Laboratory Analysis (2018) Vol. 32, Iss. 9
Open Access | Times Cited: 25
Upregulation of microRNA‐218 reduces cardiac microvascular endothelial cells injury induced by coronary artery disease through the inhibition of HMGB1
Wenhui Gao, Hanbin Cui, Qianjun Li, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 3, pp. 3079-3095
Closed Access | Times Cited: 25
Talk about micromanaging! Role of microRNAs in intestinal barrier function
Rana Al–Sadi, Jessica Engers, Raz Abdulqadir
AJP Gastrointestinal and Liver Physiology (2020) Vol. 319, Iss. 2, pp. G170-G174
Closed Access | Times Cited: 22
Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
Ahmed Zedan, Søren Garm Blavnsfeldt, Torben Frøstrup Hansen, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0179113-e0179113
Open Access | Times Cited: 23
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 2, pp. 308-323
Closed Access | Times Cited: 11
The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases
Horia Minea, Ana-Maria Sîngeap, Manuela Minea, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8420-8420
Open Access | Times Cited: 2
microRNA in inflammatory bowel disease at a glance
Vahab Alamdari-Palangi, Farzaneh Vahedi, Zahra Shabaninejad, et al.
European Journal of Gastroenterology & Hepatology (2020) Vol. 32, Iss. 2, pp. 140-148
Closed Access | Times Cited: 16
MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice
Guotao Wu, Dan Zhang, Lichao Yang, et al.
Molecular Immunology (2022) Vol. 146, pp. 57-68
Open Access | Times Cited: 10
Green Tea Extract Containing Piper retrofractum Fruit Ameliorates DSS-Induced Colitis via Modulating MicroRNA-21 Expression and NF-κB Activity
Mak-Soon Lee, Jumi Lee, Yangha Kim
Nutrients (2022) Vol. 14, Iss. 13, pp. 2684-2684
Open Access | Times Cited: 9
miR-126 in Peripheral Blood Mononuclear Cells Negatively Correlates with Risk and Severity and is Associated with Inflammatory Cytokines as well as Intercellular Adhesion Molecule-1 in Patients with Coronary Artery Disease
Hui-liang Wu, Jing Zhang
Cardiology (2018) Vol. 139, Iss. 2, pp. 110-118
Closed Access | Times Cited: 16
MicroRNA expression in inflammatory bowel disease-associated colorectal cancer
Thaís Gagno Grillo, Ana Elisa Valencise Quaglio, Rodrigo Fedatto Beraldo, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 9, pp. 995-1016
Open Access | Times Cited: 12
Mucosal microRNAs relate to age and severity of disease in ulcerative colitis
Mikkel Malham, Jaslin James, Christian Jakobsen, et al.
Aging (2021) Vol. 13, Iss. 5, pp. 6359-6374
Open Access | Times Cited: 11
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)
Anja Fejrskov, Johannes David Füchtbauer, Lóa Davíðsdóttir, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e083144-e083144
Open Access | Times Cited: 1
MiR-124a Mediates the Impairment of Intestinal Epithelial Integrity by Targeting Aryl Hydrocarbon Receptor in Crohn’s Disease
Xiaojing Zhao, Jiajia Li, Jingjing Ma, et al.
Inflammation (2020) Vol. 43, Iss. 5, pp. 1862-1875
Closed Access | Times Cited: 9
MicroRNA23a Overexpression in Crohn’s Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier
Richard Felwick, Geraint Dingley, Rocío T. Martínez-Nuñez, et al.
Journal of Crohn s and Colitis (2019) Vol. 14, Iss. 3, pp. 381-392
Open Access | Times Cited: 9
Combined MicroRNA In Situ Hybridization and Immunohistochemical Detection of Protein Markers
Boye Schnack Nielsen, Kim Holmstrøm
Methods in molecular biology (2019), pp. 271-286
Closed Access | Times Cited: 6
Estimating tissue-specific TNF mRNA levels prior to anti-TNFα treatment may support therapeutic optimisation in IBD patients
Jaslin James, Boye Schnack Nielsen, Ebbe Langholz, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 58, Iss. 11, pp. 1237-1245
Open Access | Times Cited: 2
The significance of serum marker levels for assessing the status and prognosis of patients with inflammatory bowel disease
М. В. Кручинина, И. О. Светлова, М. Ф. Осипенко, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 4, pp. 121-132
Open Access | Times Cited: 2
Infliximab therapy decreases the expression of serum and faecal miR‐126 and miR‐20a in paediatric Crohn's disease: A pilot study
Marianna Casertano, Maria Consiglia Trotta, Sabrina Cenni, et al.
Acta Paediatrica (2023) Vol. 113, Iss. 3, pp. 590-597
Closed Access | Times Cited: 2
Role of the long non‑coding RNA HOTAIR/miR‑126 axis in an in vitro psoriasis model
Weifeng Zha, Bo Guo, Shuyue Chen, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 4

Scroll to top